XM does not provide services to residents of the United States of America.

Top of the Street: BMW, Volkswagen, OMV, IMCD, Barratt, Novartis



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-Top of the Street: BMW, Volkswagen, OMV, IMCD, Barratt, Novartis</title></head><body>

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:


** Exane BNP Paribas cuts BMW BMWG.DE to "neutral" from "outperform" and raises Volkswagen VOWG_p.DE to "outperform" from "neutral" citing the need for strong product flow and cost action as the automotive industry faces a new deflationary era, with premium mix peaking and growth increasingly reliant on emerging markets

** UBS raises Austrian energy group OMV OMVV.VI to "buy" from "neutral," citing high distribution yield, and the end of the downgrade cycle

** Jefferies upgrades Dutch specialty chemicals maker IMCD IMCD.AS to "buy" from "hold," saying it observes better market conditions for specialty chemicals distributors, leading to a recovery in organic revenue growth and enhanced operational leverage from the second half of the year

** Jefferies cuts Swiss drugmaker Novartis NOVN.S to "hold" from "buy", citing lack of mid-term catalysts after the recent upgrade cycle


INITIATIONS AND REINSTATEMENTS

** Barclays initiates Britain's homebuilder Barratt Developments BDEV.L at "overweight" and a target price of £641 pounds ($841.06), citing a compelling value opportunity after a de-rating and potential revenue synergies


(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)






($1 = 0.7621 pounds)



Reporting by Anna Peverieri and Anastasiia Kozlova

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.